Harmony Biosciences Q3 EPS $0.81 Misses $1.10 Estimate, Sales $268.917M Miss $273.078M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Misses
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $1.10 by 26.36 percent. This is a 25 percent decrease over earnings of $1.08 per share from
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $1.10 by 26.36 percent. This is a 25 percent decrease over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $268.917 million which missed the analyst consensus estimate of $273.078 million by 1.52 percent. This is a 12.30 percent increase over sales of $239.455 million the same period last year.